PTIX
USDProtagenic Therapeutics Inc. Common Stock
$2.150-0.070 (-3.153%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.220
High
$2.290
Low
$2.140
Volume
0.03M
Company Fundamentals
Market Cap
4.1M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
2.71M
Exchange
NCM
Currency
USD
52-Week Range
Low $2.09Current $2.150High $15.26
Related News
AccessWire
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
Delay Attributable to Merger-Related Financial Consolidation NEW YORK, NY / ACCESS Newswire / August 22, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company developing novel neuro-active
View more
AccessWire
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
Dosing Completion Expected by End of August; Phase 2 Trial Expected to Begin in 1Q 2026 NEW YORK, NY / ACCESS Newswire / August 21, 2025 / Protagenic Therapeutics, Inc. , a biopharmaceutical company
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.